yeti authorized

ex-99d2g019.jpg

ex-99d2g019.jpg

Price: $ 64.99

5(775)

https://cdn.kscope.io/c09bfa1f08c4b419af2dfca86b68d56a-ex-99d2g015.jpg

SEC Filing Aclaris Therapeutics, Inc.

http://www.streetinsider.com/images/secattach/20200220/16499285_ex-99d2g037.jpg

Form 8-K STORE CAPITAL Corp For: Feb 20

https://cdn.kscope.io/6cf01621d2b950f3b3f2557d220d61aa-ex-99d2g019.jpg

SEC Filing Aclaris Therapeutics, Inc.

https://www.sec.gov/Archives/edgar/data/1327607/000155837019006463/ex-99d2g003.jpg

ex-99d2g003.jpg

http://www.streetinsider.com/images/secattach/20200113/16326288_ex-99d2g038.jpg

Form 8-K Axogen, Inc. For: Jan 13

https://www.sec.gov/Archives/edgar/data/1527590/000155837019004513/ex-99d2g019.jpg

ex-99d2g019.jpg

http://www.streetinsider.com/images/secattach/20170606/12983235_ex-99d2g001.gif

Form 8-K Blueprint Medicines Corp For: Jun 05

https://www.sec.gov/Archives/edgar/data/856982/000155837019009454/ex-99d2g007.jpg

MERIT MEDICAL SYSTEMS INC - DISCLOSURE REGARDING FORWARD-LOOKING STATEMENTS This presentation and any accompanying management commentary include “forward-looking statements,” as defined within applicable securities laws and regulations. All statements

https://cdn.kscope.io/c09bfa1f08c4b419af2dfca86b68d56a-ex-99d2g013.jpg

SEC Filing Aclaris Therapeutics, Inc.

https://cdn.kscope.io/6cf01621d2b950f3b3f2557d220d61aa-ex-99d2g018.jpg

SEC Filing Aclaris Therapeutics, Inc.

https://cdn.kscope.io/f2478582bf927f01fd51b1d27f9ffd1e-ex-99d1g001.jpg

SEC Filing Aclaris Therapeutics, Inc.

https://cdn.kscope.io/f2478582bf927f01fd51b1d27f9ffd1e-ex-99d2g023.jpg

SEC Filing Aclaris Therapeutics, Inc.

https://www.sec.gov/Archives/edgar/data/1327607/000155837019006463/ex-99d2g001.jpg

ex-99d2g001.jpg

https://www.sec.gov/Archives/edgar/data/1579428/000155837019011521/ex-99d2g019.jpg

EDGAR Filing Documents for 0001558370-19-011521

You may also like